))
Ep. 18 - Is Reefer Madness Over? Don't Count On It... (Part 1)
Manage episode 418585040 series 3546136
Conteúdo fornecido por Dr. Denise Foster. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Dr. Denise Foster ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
The Drug Enforcement Administration, after a recommendation by the Department of Health and Human Services, has indicated it will be moving cannabis from Schedule I to Schedule III in the Controlled Substances Act. This proposed move cannabis to a lower schedule supports what science has indicated after 80 years of research - cannabis is medicine with a low potential for abuse and harm.
But in reality, rescheduling will only benefit businesses and the medical industrial complex. Why? Schedule III drugs are still under the control of the DEA and more significantly, Big Pharma. In this episode, we highlight the potential good, bad, and downright ugly repercussions of this proposed rescheduling.
33 episódios
Compartilhar
